RadIal Versus Femoral InvEstigation in ST Elevation Acute Coronary Syndrome
NCT ID: NCT01420614
Last Updated: 2012-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1001 participants
INTERVENTIONAL
2009-01-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
NCT06013813
Arterial Access for Coronary Intervention in Myocardial Infarction
NCT00356044
Trial Comparing Radial and Femoral Approach in Primary Percutaneous Coronary Intervention (PCI)
NCT01136187
Comparison of Radial and Ulnar Artery Intervention in Patients With ST Elevated Myocardial Infarction
NCT04183140
Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease
NCT02748603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Before arterial stick for percutaneous access, patients will be randomized according to sealed numbered envelopes. Subsequently, arterial access will be obtained and the diagnostic/interventional procedure will be performed according to routine clinical practice, leaving ancillary medications, choice of devices and means of hemostasis at the physician's discretion.
In the randomization process all participating centers will be equally stratified to avoid statistical unbalance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Radial
group of patients undergoing primary angioplasty by transradial approach
Radial approach
diagnostic and interventional procedures by radial artery access
Femoral
group of patients undergoing primary angioplasty by transfemoral approach
Femoral approach
diagnostic and interventional procedures by femoral artery access
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femoral approach
diagnostic and interventional procedures by femoral artery access
Radial approach
diagnostic and interventional procedures by radial artery access
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has no contraindication to percutaneous arterial access by both and transfemoral route.
3. Subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical site.
4. Patient and the treating physician agree that the subject will comply with all follow-up evaluations.
Exclusion Criteria
2. Subject has had a recent stroke or TIA (\<4 weeks), irrespective of age.
3. Patient has an international normalized ratio (INR) \> 2.0, or other severe bleeding diathesis
4. The patient is pregnant or breastfeeding.
5. Known allergies to: aspirin, clopidogrel and ticlopidine, heparin, IIb/IIIa inhibitors, stainless steel, or contrast agent (which cannot be adequately premedicated).
7.Subject is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints.
8.Prior participation in this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Policlinico Casilino ASL RMB
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enrico Romagnoli
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ernesto Lioy, MD
Role: PRINCIPAL_INVESTIGATOR
Policlinico Casilino
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Università di Modena e Reggio Emilia
Modena, Modena, Italy
Ospedale Sandro Pertini
Rome, Rome, Italy
Policlinico Casilino
Rome, Rome, Italy
University of Turin, San Giovanni Battista Hospital
Turin, Turin, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi G. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9. doi: 10.1016/j.jacc.2012.06.017. Epub 2012 Aug 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PC-03ER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.